Activity Number:
|
257
|
Type:
|
Topic Contributed
|
Date/Time:
|
Tuesday, August 9, 2005 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #304309 |
Title:
|
The Design of the VA/NINDS Randomized Clinical Trial of Deep Brain Stimulation for Treatment of Parkinson's Disease
|
Author(s):
|
Domenic Reda*+ and Kwan Hur and Kenneth Follett and Frances Weaver and Matthew Stern and Crystal Harris
|
Companies:
|
U.S. Department of Veterans Affairs and U.S. Department of Veterans Affairs and University of Nebraska Medical Center and VA Hospital and VA Medical Center and VA Medical Center
|
Address:
|
53 Chesterfield Court, Cooperative Studies Program, Burr Ridge, IL, 60527, United States
|
Keywords:
|
Randomized Clinical Trials ; Medical Devices ; Deep Brain Stimulation ; Parkinson's Disease
|
Abstract:
|
A common problem in the design and conduct of randomized clinical trials is the lengthy time often seen between study planning and publication of results. This is particularly problematic in rapidly evolving medical specialties where a study may become obsolete before its completion. One example is in the treatment of advanced Parkinson's Disease when medications are no longer sufficient to control symptoms. In a relatively short time, pallidotomy---an ablative surgical intervention---came into widespread use before being replaced rapidly with deep brain stimulation (DBS), involving a functional lesion. Further, DBS devices have undergone technical improvements since their introduction. In the VA/NINDS Trial of Deep Brain Stimulation for the Treatment of Parkinson's Disease, the original study design underwent major modifications twice before data collection began because of these major shifts. Following study implementation, further revisions in the study design and conduct were needed to address changes in the regulatory status of the devices. his talk will trace the evolution of the study design and the events that transpired necessitating these revisions.
|